
|Articles|July 9, 2019
Saama and Tufts Team Up to Assess Technology Adoption
Advertisement
Saama Technologies, Inc., has announced a collaboration with researchers at the Tufts Center for the Study of Drug Development at Tufts University School of Medicine to ascertain how biopharmaceutical companies optimize automation and information technologies. Research is set to being this fall.
For more information about the upcoming research, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5






.png)



.png)



.png)
.png)
